MiMedx Group Inc Stock Nasdaq
Equities
US6024961012
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 357M | Sales 2025 * | 403M | Capitalization | 961M |
---|---|---|---|---|---|
Net income 2024 * | 43M | Net income 2025 * | 56M | EV / Sales 2024 * | 2.69 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.38 x |
P/E ratio 2024 * |
21.1
x | P/E ratio 2025 * |
16.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.24% |
Latest transcript on MiMedx Group Inc
Managers | Title | Age | Since |
---|---|---|---|
Joe Capper
CEO | Chief Executive Officer | 60 | 23-01-26 |
Douglas Rice
DFI | Director of Finance/CFO | 58 | 23-07-04 |
John R. Harper
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Hawkins
BRD | Director/Board Member | 70 | 20-07-01 |
Phyllis Gardner
BRD | Director/Board Member | 73 | 21-03-07 |
K. Newton
BRD | Director/Board Member | 61 | 19-06-18 |
1st Jan change | Capi. | |
---|---|---|
-19.12% | 131M | |
+10.84% | 63.05M | |
-15.49% | 61.84M | |
+13.60% | 61.14M | |
-2.40% | 50.36M |